# Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management

> **NCT07464808** · NA · RECRUITING · sponsor: **Ain Shams University** · enrollment: 25 (estimated)

## Conditions studied

- Venous Thromboembolic Event

## Interventions

- **OTHER:** follow up venous thrombo embolic events with routine clexan dose modification guided by anti factor 10 assay
- **OTHER:** follow up venous thromboembolic events with no routine clexan dosage modification and no usage of anti factor 10 assay

## Key facts

- **NCT ID:** NCT07464808
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-28
- **Primary completion:** 2027-01-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07464808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07464808, "Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07464808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*